Literature DB >> 11471092

Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study.

C Delcourt1, F Michel, A Colvez, A Lacroux, M Delage, M H Vernet.   

Abstract

The POLA study (June 1995 through July 1997) is a population-based study on cataract and age-related macular degeneration (AMD) and their risk factors in 2584 residents of Séte (South of France), aged 60--95 years. Classification of AMD was performed on 50 degrees fundus photographs, according to an international classification. The presence of cardiovascular disease and its risk factors was determined by interviewer-based questionnaire, clinical examination (anthropometry, blood pressure) and fasting plasma measurements. Using a logistic model adjusted for age and gender, late AMD was not significantly associated with a history of cardiovascular disease, diabetes, use of hypocholesterolemic drugs, hypertension, blood pressure or plasma lipids. Obese subjects (body mass index greater than 30 kg/m( 2)) had a 2.29-fold (95% confidence interval (CI): 1.00--5.23) and 1.54-fold (CI: 1.05--2.26) increased risk of late AMD and pigmentary abnormalities in comparison with lean subjects. Finally, the risk of soft drusen was decreased in those subjects with a history of cardiovascular disease (odds-ratio (OR) = 0.72, CI: 0.54--0.97), and increased with increasing levels of HDL-cholesterol (OR = 1.52, CI: 1.14--2.02). None of these results were modified by further adjustments for smoking, educational level and plasma alpha-tocopherol. These results need to be confirmed by other studies, which ideally should be longitudinal and prospective.

Entities:  

Mesh:

Year:  2001        PMID: 11471092     DOI: 10.1076/opep.8.4.237.1613

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  72 in total

Review 1.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

2.  The association between statin use and age related maculopathy.

Authors:  G McGwin; C Owsley; C A Curcio; R J Crain
Journal:  Br J Ophthalmol       Date:  2003-09       Impact factor: 4.638

Review 3.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

4.  High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture.

Authors:  B Y Ishida; K G Duncan; K R Bailey; J P Kane; D M Schwartz
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 5.  Role of Lipids in Retinal Vascular and Macular Disorders.

Authors:  Gunjan Prakash; Rachit Agrawal; Tanie Natung
Journal:  Indian J Clin Biochem       Date:  2016-03-08

Review 6.  Plasma apolipoproteins and risk for age related maculopathy.

Authors:  N Dashti; G McGwin; C Owsley; C A Curcio
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

Review 7.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

8.  [Age-related macular degeneration and risk of stroke].

Authors:  V Biousse; M-G Bousser; A Gaudric
Journal:  J Fr Ophtalmol       Date:  2008-01       Impact factor: 0.818

9.  Statin use and the five-year incidence and progression of age-related macular degeneration.

Authors:  Ronald Klein; Michael D Knudtson; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2007-05-02       Impact factor: 5.258

10.  Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up.

Authors:  Paul T Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.